Is the price fair?
What NGVT's price assumes
Today's price asks for −3.1% free cash flow growth a year; over the last three years Ingevity Corporation delivered 17%, less than the record.
2.18
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 9.6%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- −3.1%
Growth the price implies · The price pays for −3.1% free cash flow growth a year for a decade; the business has delivered +17% a year over the last three.
- Price / book
- 66.0
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 66.0
- Free cash flow, trailing twelve months
- $246M
- Market capitalisation
- $2.55B
- 3-year revenue growth
- −10%
- 3-year free cash flow growth
- +17%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #7 of 36 by Smart Score